지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives: Systems related to the production, authorization, and listing for insurance of herbal medicine products were compared between South Korea and Taiwan to illuminate herbal medicine products system issues in South Korea.
Methods: Papers, and laws and policies related to the production, authorization, and listing for insurance of herbal medicine products in South Korea and Taiwan are analyzed to create the primary documents. The documents from South Korea were screened with the advice of a specialist, while those from Taiwan have been verified through local investigation and with the help of a related specialist. The screened documents were then compared and analyzed in the order of the systems related to the production, authorization, and listing for insurance of herbal medicine products.
Results: The systems related to the production of herbal medicine products satisfy GMP requirements in both countries, while Taiwan has more specialized systems related to the production of herbal medicine products and a more strict authorization program as compared to South Korea. While South Korea has most of the herbal medicine products classified as non-prescription drugs, Taiwan has them as prescription drugs. And while South Korea does not allow new herbal medicine products to be listed for insurance, Taiwan allows for once-a-year application toward listing for insurance.
Conclusions: In order to ensure the safe and effective use of herbal medicine products, systems related to the production, authorization, and listing for insurance of herbal medicine products are to be established, while the categorization of medicine products principally used by Korean medicine doctors should be prepared. Furthermore, prescription by a Korean medicine doctor for new drugs made with natural products and their listing for insurance need to be encouraged.
Methods: Papers, and laws and policies related to the production, authorization, and listing for insurance of herbal medicine products in South Korea and Taiwan are analyzed to create the primary documents. The documents from South Korea were screened with the advice of a specialist, while those from Taiwan have been verified through local investigation and with the help of a related specialist. The screened documents were then compared and analyzed in the order of the systems related to the production, authorization, and listing for insurance of herbal medicine products.
Results: The systems related to the production of herbal medicine products satisfy GMP requirements in both countries, while Taiwan has more specialized systems related to the production of herbal medicine products and a more strict authorization program as compared to South Korea. While South Korea has most of the herbal medicine products classified as non-prescription drugs, Taiwan has them as prescription drugs. And while South Korea does not allow new herbal medicine products to be listed for insurance, Taiwan allows for once-a-year application toward listing for insurance.
Conclusions: In order to ensure the safe and effective use of herbal medicine products, systems related to the production, authorization, and listing for insurance of herbal medicine products are to be established, while the categorization of medicine products principally used by Korean medicine doctors should be prepared. Furthermore, prescription by a Korean medicine doctor for new drugs made with natural products and their listing for insurance need to be encouraged.
목차
서론
연구방법
결과
고찰
결론
참고문헌
참고문헌 (31)
참고문헌 신청
1. [단행본] - GLOBAL HEALTH CARE / 2011 / Production & Distribution of Herbal Medicine(Ⅰ) / GLOBAL HEALTH CARE
2. [기타자료] - Committee on Chinese Medicine and Pharmacy / 2009 / Yearbook of Herbal Medicine Industry 2009 / Committee on Chinese Medicine and Pharmacy, Department of Health
3. [기타자료] - Pusan National University School of Korean Medicine / 2009 / 2009 Yearbook of Oriental Medicine in Korea : 164 ~
4. [단행본] - The Bureau of National Health Insurance / 2011 / Global Budget system / The Bureau of National Health Insurance : 9 ~
5. [기타자료] - Committee on Chinese Medicine and Pharmacy / 2009 / Yearbook of Herbal Medicine Industry 2009 / Committee on Chinese Medicine and Pharmacy, Department of Health
2. [기타자료] - Committee on Chinese Medicine and Pharmacy / 2009 / Yearbook of Herbal Medicine Industry 2009 / Committee on Chinese Medicine and Pharmacy, Department of Health
3. [기타자료] - Pusan National University School of Korean Medicine / 2009 / 2009 Yearbook of Oriental Medicine in Korea : 164 ~
4. [단행본] - The Bureau of National Health Insurance / 2011 / Global Budget system / The Bureau of National Health Insurance : 9 ~
5. [기타자료] - Committee on Chinese Medicine and Pharmacy / 2009 / Yearbook of Herbal Medicine Industry 2009 / Committee on Chinese Medicine and Pharmacy, Department of Health
이 논문의 저자 정보
이 논문과 함께 이용한 논문
특정 한방 약물치료와 외용법을 혼용한 소아 아토피 피부염 치료의 효과
강희
,
곽민정
,
김정진
외 1명
대한동의병리학회 학술대회논문집
2005
.12
암 치료의 한의학적 접근 : M. μ integrative cancer의 임상을 중심으로
Lee
,
Soo Kyung
대한동의병리학회 학술대회논문집
2006
.11
동서양 의학에서 바라본 몸과 마음의 상호관계
이건호
한국정신과학회 학술대회논문집
2013
.10
한방의료기관의 한약 관리 및 가격 현황에 대한 연구
황대선
,
신현규
대한한의학회지
2011
.09
한방치료를 통해 호전된 폐쇄성수면무호흡증 환자 3례에 대한 임상 보고
정환석
,
김호선
대한한의학회지
2012
.03
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2014-519-000272709